Conferences

July 28, 2020
By Elise Mak
Emerging biotechs remain major driver for global innovation
Emerging companies continue to have a bigger role in pushing biotech innovation, and their presence is more important than ever, given the race for a COVID-19 solution. Those companies’ role in global R&D and new drug approvals was stressed by experts at the current BIO Asia-Taiwan conference.
July 28, 2020
By Elise Mak
Boosted by COVID-19 success, Taiwan life sciences sector building government, investor support
With no new cases reported for more than 100 days, Taiwan appears to have successfully contained the spread of COVID-19 and has drawn attention to its medical achievements.
July 28, 2020
By Elise Mak
Local vs. global: COVID-19 highlights supply chain debate among industry challenges
In the shadow of COVID-19, experts at the BIO Asia-Taiwan conference on Wednesday warned of present and future challenges for the biotech industry. Changes in manufacturing logistics and financial distress will continue to cause concern for the industry.

Emerging biotechs remain major driver for global innovation